Allameh A, Niayesh-Mehr R, Aliarab A, Sebastiani G, Pantopoulos K
Antioxidants (Basel). 2023; 12(9).
PMID: 37759956
PMC: 10525124.
DOI: 10.3390/antiox12091653.
Di Ciaula A, Bonfrate L, Krawczyk M, Fruhbeck G, Portincasa P
Int J Mol Sci. 2022; 23(5).
PMID: 35269779
PMC: 8910376.
DOI: 10.3390/ijms23052636.
Seitz H, Neuman M
J Clin Med. 2021; 10(4).
PMID: 33669694
PMC: 7921942.
DOI: 10.3390/jcm10040858.
Dharmawansa K, Hoskin D, Rupasinghe H
Int J Mol Sci. 2020; 21(18).
PMID: 32911639
PMC: 7554903.
DOI: 10.3390/ijms21186555.
Jia Y, Ji P, French S
Biomedicines. 2020; 8(7).
PMID: 32630199
PMC: 7399975.
DOI: 10.3390/biomedicines8070189.
Potential role of gut microbiota, the proto-oncogene PIKE (Agap2) and cytochrome P450 CYP2W1 in promotion of liver cancer by alcoholic and nonalcoholic fatty liver disease and protection by dietary soy protein.
Ronis M, Mercer K, Shankar K, Pulliam C, Pedersen K, Ingelman-Sundberg M
Chem Biol Interact. 2020; 325:109131.
PMID: 32417163
PMC: 7370542.
DOI: 10.1016/j.cbi.2020.109131.
Systematic Review with Meta-Analysis: Low-Level Alcohol Consumption and the Risk of Liver Cancer.
Park H, Shin S, Joo I, Song D, Jang J, Park J
Gut Liver. 2020; 14(6):792-807.
PMID: 32135583
PMC: 7667924.
DOI: 10.5009/gnl19163.
Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma.
Kumar R, Goh B, Kam J, Chang P, Tan C
Clin Mol Hepatol. 2020; 26(2):196-208.
PMID: 31914720
PMC: 7160352.
DOI: 10.3350/cmh.2019.0012.
Evaluating Correlates of Awareness of the Association between Drinking Too Much Alcohol and Cancer Risk in the United States.
Wiseman K, Klein W
Cancer Epidemiol Biomarkers Prev. 2019; 28(7):1195-1201.
PMID: 31043419
PMC: 6606368.
DOI: 10.1158/1055-9965.EPI-18-1010.
Effects of vitamin C and E on toxic action of alcohol on partial hepatectomy-induced liver regeneration in rats.
Okamura Y, Omori A, Asada N, Ono A
J Clin Biochem Nutr. 2018; 63(1):50-57.
PMID: 30087544
PMC: 6064813.
DOI: 10.3164/jcbn.17-96.
Different roles of FAT10, FOXO1, and ADRA2A in hepatocellular carcinoma tumorigenesis in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH).
Jia Y, French B, Tillman B, French S
Exp Mol Pathol. 2018; 105(1):144-149.
PMID: 30009772
PMC: 6093215.
DOI: 10.1016/j.yexmp.2018.07.005.
Alcohol dehydrogenase and aldehyde dehydrogenase in malignant neoplasms.
Orywal K, Szmitkowski M
Clin Exp Med. 2016; 17(2):131-139.
PMID: 26886278
PMC: 5403859.
DOI: 10.1007/s10238-016-0408-3.
Identification of Chromosomal Aberrations by Using Trypsin G-banding in Hepatocellular Carcinoma Patients (HCC) in Tamil Nadu, India.
Mohana Devi S, Balachandar V, Murugan P, Sasikala K, Manikantan P, Venkatakrishnan L
Trop Life Sci Res. 2014; 21(1):31-46.
PMID: 24575188
PMC: 3819068.
Alcohol consumption and PSA-detected prostate cancer risk--a case-control nested in the ProtecT study.
Zuccolo L, Lewis S, Donovan J, Hamdy F, Neal D, Davey Smith G
Int J Cancer. 2012; 132(9):2176-85.
PMID: 23024014
PMC: 3786564.
DOI: 10.1002/ijc.27877.
Risk of upper aerodigestive tract cancer and type of alcoholic beverage: a European multicenter case-control study.
Marron M, Boffetta P, Moller H, Ahrens W, Pohlabeln H, Benhamou S
Eur J Epidemiol. 2012; 27(7):499-517.
PMID: 22692594
DOI: 10.1007/s10654-012-9699-1.
Cancer-related disparities and opportunities for intervention in Northern Plains American Indian communities.
Watanabe-Galloway S, Flom N, Xu L, Duran T, Frerichs L, Kennedy F
Public Health Rep. 2011; 126(3):318-29.
PMID: 21553659
PMC: 3072852.
DOI: 10.1177/003335491112600304.
Non-viral causes of hepatocellular carcinoma.
Van Thiel D, Ramadori G
J Gastrointest Cancer. 2010; 42(4):191-4.
PMID: 20820946
PMC: 3212675.
DOI: 10.1007/s12029-010-9195-3.
Pathogenesis of alcoholic liver disease: the role of nuclear receptors.
Gyamfi M, Wan Y
Exp Biol Med (Maywood). 2010; 235(5):547-60.
PMID: 20463294
PMC: 3908670.
DOI: 10.1258/ebm.2009.009249.
Histone modification-mediated CYP2E1 gene expression and apoptosis of HepG2 cells.
Yang H, Nie Y, Li Y, Wan Y
Exp Biol Med (Maywood). 2010; 235(1):32-9.
PMID: 20404016
PMC: 3991239.
DOI: 10.1258/ebm.2009.009252.
Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine.
Hanczko R, Fernandez D, Doherty E, Qian Y, Vas G, Niland B
J Clin Invest. 2009; 119(6):1546-57.
PMID: 19436114
PMC: 2689120.
DOI: 10.1172/JCI35722.